락타아제 시장 규모 : 공급원별, 용도별, 형태별, 성장 전망, 지역별 전망, 세계 예측(2024-2032년)

Lactase Market is anticipated to record a CAGR of 6.3% from 2024 to 2032, driven by the increasing prevalence of lactose intolerance among the global population. It affects a substantial portion of the population, leading to digestive discomfort upon consuming dairy products. As awareness about lactose intolerance grows, there is a rising demand for lactase supplements to aid in the digestion of lactose, thereby driving the growth of the market.

Additionally, with an increasing number of consumers opting for plant-based or lactose-free alternatives due to health, ethical, or dietary reasons, F&B manufacturers are incorporating lactase enzymes into their products to cater to this demand. In February 2024, food and drinks manufacturing & distribution company Kerry Group acquired the combined lactase enzymes business of bioscience companies Chr Hansen and Novozymes.

Lactase industry is segmented on the basis of source, application, form, and region.

Plant segment is poised for substantial growth in the forecast period, due to the increasing consumer preference for plant-based alternatives and the rising demand for lactose-free products. As more individuals adopt plant-based diets for health, environmental, or ethical reasons, there is a growing need for lactase enzymes derived from plant sources to facilitate the production of dairy-free and lactose-free products. Additionally, advancements in biotechnology and enzyme engineering have enabled the extraction and purification of lactase enzymes from various plant sources, including fungi and bacteria.

Ice cream segment will generate notable revenues for the market during 2024-2032, as its popularity continues to rise globally, particularly among lactose-intolerant individuals seeking indulgent yet digestible treats. Manufacturers are increasingly incorporating lactase enzymes into their formulations to create lactose-free or reduced-lactose ice cream varieties, catering to a broader consumer base and addressing dietary restrictions. Moreover, innovations in enzyme technology have led to the development of lactase enzymes that maintain the texture, flavor, and creaminess of traditional ice cream while effectively breaking down lactose.

Europe lactase industry is slated to witness a significant growth rate through 2032, attributed to the stringent regulatory standards regarding food safety. The growing inclination of lactose-free and dairy-free diets among European consumers, driven by health consciousness and dietary preferences, fuels the product demand. Moreover, advancements in enzyme technology and bioprocessing methods, coupled with increasing investments in R&D further stimulates the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & workings
• 1.3 Forecast parameters
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Data mining source
    • 1.4.2.1 Paid source
    • 1.4.2.2 Public source

Chapter 2 Executive Summary

• 2.1 Lactase industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Source trends
• 2.4 Application trends
• 2.5 Form trends
• 2.6 Regional trends

Chapter 3 Lactase Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Raw material suppliers
  • 3.1.2 Manufacturers
  • 3.1.3 Profit margin analysis
  • 3.1.4 Distribution channel analysis
  • 3.1.5 End-users
  • 3.1.6 Vendor matrix
    • 3.1.6.1 List of key raw material suppliers
    • 3.1.6.2 List of key manufacturers/suppliers
    • 3.1.6.3 Lits of key/potential customers
• 3.2 Technology landscape
• 3.3 Regulatory landscape
  • 3.3.1 North America
  • 3.3.2 Europe
  • 3.3.3 Asia Pacific
  • 3.3.4 Latin America
  • 3.3.5 Middle East & Africa
• 3.4 Industry impact forces
  • 3.4.1 Growth drivers
    • 3.4.1.1 Rising prevalence of lactose intolerance
    • 3.4.1.2 Increasing demand for Lactose-Free and Dairy-Free products
    • 3.4.1.3 Expanding application in food and beverage industry
  • 3.4.2 Industry pitfalls & challenges
    • 3.4.2.1 Perceived high cost
• 3.5 Pricing analysis
  • 3.5.1 Regional pricing
    • 3.5.1.1 North America
    • 3.5.1.2 Europe
    • 3.5.1.3 Asia Pacific
    • 3.5.1.4 Latin America
    • 3.5.1.5 Middle East & Africa
  • 3.5.2 Cost structure analysis
    • 3.5.2.1 R&D cost
    • 3.5.2.2 Manufacturing & equipment cost
    • 3.5.2.3 Raw material cost
    • 3.5.2.4 Distribution cost
    • 3.5.2.5 Operating cost
    • 3.5.2.6 Miscellaneous cost
• 3.6 Innovation & sustainability
  • 3.6.1 Patent analysis
• 3.7 Growth potential analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share, 2023
  • 4.2.1 Company market share, by region, 2023
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 Latin America
    • 4.2.1.5 Middle East & Africa
• 4.3 Competitive analysis of market player
• 4.4 Competitive positioning matrix
• 4.5 Strategic outlook matrix

Chapter 5 Lactase Market Size and Forecast, By Source 2018 - 2032

• 5.1 Key source trends
• 5.2 Animal
• 5.3 Fungus
• 5.4 Plants

Chapter 6 Lactase Market Size and Forecast, By Application2018 - 2032

• 6.1 Key application trend
• 6.2 Milk
• 6.3 Yogurt
• 6.4 Ice cream
• 6.5 Cheese
• 6.6 Dietary supplement
• 6.7 Other

Chapter 7 Lactase Market Size and Forecast, By Form 2018 - 2032

• 7.1 Key form trends
• 7.2 Liquid
• 7.3 Dry

Chapter 8 Lactase Market Size and Forecast, By Region 2018 - 2032

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Indonesia
  • 8.4.7 Malaysia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Amano Enzyme Inc.
• 9.2 Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
• 9.3 Armor Pharma
• 9.4 BASF SE
• 9.5 Chr. Hansen Holding A/S
• 9.6 DFE Pharma
• 9.7 DSM Nutritional Products
• 9.8 Kerry Group Plc
• 9.9 Lactose India Limited
• 9.10 Meggle Excipients & Technology
• 9.11 Merck & Co., KgAa
• 9.12 Novozymes A/S
• 9.13 Valio Ltd.